Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Review

Published on 19 May 2025

A review on anti-cancer properties of quercetin in gastric cancer

in Pharmacology of Anti-Cancer Drugs

Xiaoxia Xie
Yan Wei

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1563229

1,041 views

Original Research

Published on 19 May 2025

Knowledge, attitudes, and practices of healthcare providers toward ADR reporting regarding thiopurine drugs for the treatment of acute lymphoblastic leukemia at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia

in Pharmacology of Anti-Cancer Drugs

Eyuel Kassa
Mastewal Birhan
Mulugeta Ayalew
Aschalew Gelaw
Abdulkader Mohamedsaid Gidey
Degalem Tilahun Worku
Awole Mekonen
Ermias Teklehaimanot
Assefa Asnakew
Alazar Amare

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1486415

775 views

Systematic Review

Published on 16 May 2025

Efficacy and safety of neoadjuvant PD-1 inhibitors or PD-L1 inhibitors combined with chemoradiotherapy for locally advanced rectal cancer: a systematic review and meta-analysis

in Pharmacology of Anti-Cancer Drugs

Jiaojiao Yu
Zhijing Wang
Mingxu Li
Hua Zhu
Xiaoxia Tang
Ke Luan
Yinhuan Zhi
Shan Yin
Yuanqi Su
Jingyan Long

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1570467

804 views

Original Research

Published on 15 May 2025

Wogonin inhibits the proliferation of prolactinoma through the PI3K/AKT signaling pathway

in Pharmacology of Anti-Cancer Drugs

Zhiyong Du
Cuiping Sun
Jiawei Wu
Hongwei Gao
Jialong Wu
You Zhou
Xuechao Wu
Liping Shen
Qing Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1546285

820 views

Original Research

Published on 15 May 2025

IL6/CCL2 from M2-polarized microglia promotes breast cancer brain metastasis and the reversal effect of β-elemene

in Pharmacology of Anti-Cancer Drugs

Qian Feng
Cai-Zhi Li
Yi-Hua Zou
Xue-Yu Wang
Xia Yang
Rong Zhang
Zhong-Qiu Liu
Rong-Rong Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1547333

896 views

Case Report

Published on 15 May 2025

Successful treatment of an elderly patient with relapsed/refractory angioimmunoblastic T-cell lymphoma with the PI3Kδ inhibitor linperlisib: a Case Report

in Pharmacology of Anti-Cancer Drugs

Ming-Qiang Chu
Ting-Juan Zhang
Qian Yang
Yuan Feng
Chao Lu
Yong-Hui Ji
Jun Qian
Jing-Dong Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1554501

677 views

Review

Published on 15 May 2025

Tumor-derived exosomes as promising tools for cancer diagnosis and therapy

in Pharmacology of Anti-Cancer Drugs

Xirui Wang
Yanfang Liu
Yaowen Jiang
Qinghua Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1596217

688 views

Review

Published on 15 May 2025

Microbiota-derived metabolites in tumorigenesis: mechanistic insights and therapeutic implications

in Pharmacology of Anti-Cancer Drugs

Si-Fu Yang
Xiao-Chen Chen
Yao-Jie Pan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1598009

760 views

Review

Published on 15 May 2025

Autophagy as a potential therapeutic target in regulating improper cellular proliferation

in Pharmacology of Anti-Cancer Drugs

Prashant Kumar
Akash Choudhary
Sumit Kinger
Yuvraj Anandrao Jagtap
Vijay Kumar Prajapati
Deepak Chitkara
Subashchandrabose Chinnathambi
Rahul Kumar Verma
Amit Mishra

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1579183

1,056 views

Original Research

Published on 15 May 2025

Preclinical studies of a PARP-targeted theranostic radiopharmaceutical for pancreatic cancer

in Pharmacology of Anti-Cancer Drugs

Jie Gao
Yuhao Wang
Ruoqi Wang
Mengya Liu
Hongliang Wang
Jianguo Li
Jin Du

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1576587

833 views

Original Research

Accepted on 14 May 2025

Ginsenosides Rh2 and Rg3 exert their anti-cancer effects on non-small cell lung cancer by regulating cell autophagy and choline-phosphatidylcholine metabolism

in Pharmacology of Anti-Cancer Drugs

Qiu-Fang Chen
Yue Qiu
Lin Wang
Bi-Li Liu
Min Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1507990

144 views

Review

Published on 14 May 2025

Based on small molecules: development and application of fibroblast activation protein inhibitors radiopharmaceutical in tumor precision therapy

in Pharmacology of Anti-Cancer Drugs

Yihui Luo
Haitian Fu
Chunjing Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1593380

995 views

Original Research

Published on 14 May 2025

Valproic acid induces ferroptosis and suppresses the proliferation of MDA-MB-231 cells by targeting FDFT1

in Pharmacology of Anti-Cancer Drugs

Shuxian Zhang
Jiazhuo Liu
Yisong Yang
Ran Tao
Xin Ren
Xingzhi Zhou
Shuangping Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1540667

769 views

Review

Published on 14 May 2025

The potential of targeting autophagy-related non-coding RNAs in the treatment of lung cancer

in Pharmacology of Anti-Cancer Drugs

Juan Li
Jimei Gan
Shenggan Shi
Juying Huang
Yong Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1551258

651 views

Review

Published on 12 May 2025

CDK4/6 inhibitors in breast cancer therapy: mechanisms of drug resistance and strategies for treatment

in Pharmacology of Anti-Cancer Drugs

Tong Gao
Ying Sun
Ping Leng
Donghua Liu
Qie Guo
Jing Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1549520

996 views

Review

Published on 12 May 2025

Challenges and hope: latest research trends in the clinical treatment and prognosis of liposarcoma

in Pharmacology of Anti-Cancer Drugs

Hongliang Liu
Xi Wang
Xiaoyu Wang
Fabo Qiu
Bin Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1529755

773 views